Pursuing patient options, Novo kicks off trial testing smaller doses of Wegovy pill
Just eight months after it introduced its oral version of semaglutide for obesity, also known as the Wegovy…
Celon Pharma’s generic semaglutide drug matches Ozempic in early study, shares jump
Aug 20 (Reuters) – Celon Pharma’s experimental semaglutide product Reduzek, a generic alternative to Novo Nordisk’s Wegovy and…
Novo Nordisk commences study for reduced Wegovy pill dosing
Novo Nordisk has begun a late-stage clinical trial to evaluate whether lower doses of its oral pill, Wegovy,…
Novo Nordisk Launches 450-Person Trial to Find Lowest Effective Wegovy Pill Dose — BigGo Finance
Novo Nordisk (NVO) has initiated a late-stage clinical trial to determine whether lower doses of its oral Wegovy…
Novo Nordisk runs new obesity experience installation in London
Novo Nordisk is running an exhibition in central London designed to start a dialogue on obesity and help…
Novo Nordisk’s Wegovy: Pioneering Weight Loss Innovation
Novo Nordisk, the Danish pharmaceutical giant, is intensifying its pursuit of weight-loss innovation with a new late-stage study…
Novo Nordisk’s Strategic Move with Wegovy: A New Study in the Obesity Drug Race
Novo Nordisk, a leading Danish pharmaceutical company, has embarked on a late-stage study to identify the minimal effective…
Obesity not a ‘zero-sum game’ as patients crave optionality, Novo CEO says: Reuters
Pushing back on the concept that there can only be one victor among branded obesity drugmakers, Novo Nordisk…
Novo Nordisk CEO Says Obesity Drug Market Won’t Be Winner-Take-All — BigGo Finance
Novo Nordisk (NVO) CEO Mike Doustdar pushed back Wednesday against the prevailing investor narrative that the booming obesity…
Lilly’s Foundayo Pill Lands First European Approval, Challenging Novo’s Wegovy in UK — BigGo Finance
Eli Lilly and Co. (LLY) has secured its first international approval for the oral weight-loss drug Foundayo, winning…
Novo Nordisk announces strategic partnership with AWS. Will it be enough to turn around its financial performance?
After kickstarting the GLP-1 wave that transformed the pharma landscape and briefly sending its market value above Denmark’s…
Novo Nordisk Swallows the Bitter Pill
Novo Nordisk Swallows the Bitter Pill – Moby THE GIST Our analysts just identified a stock with the…